Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Pharmaceutical companies could become more forthcoming with information provided to physicians on off-label usage of medications as a result of a recent decision from the U.S. Court of Appeals for the Second Circuit.

Off-label use ruling might help sued docs — Decision could affect med/mal suits